Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

SNWV

SANUWAVE Health, Inc.

Surgical & Medical Instruments & Apparatus · SIC 3841CIK 1417663Held by 1 tracked managerEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$44.0M
Net Income FY2025
$12.0M
EPS (Basic, as reported)
$1.38
Net Margin FY2025
26.8%
ROE FY2025
-56.8%
Total Equity
$(21.0M)
Shares Out
9M
Business description

SANUWAVE Health, Inc. — Surgical & Medical Instruments & Apparatus. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2010–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 1 → 44 +52.3% CAGR
Fiscal yearFY2016FY2017FY2018⚑FY2019⚑FY2020FY2021FY2022⚑FY2023⚑FY2024⚑FY2025
Revenue112141116193244
Cost of revenue(1)0(1)(1)(1)(5)(4)(6)(8)(10)
Gross profit—0113812142534
Research & development(1)(1)(2)(1)(1)(1)(1)(1)(1)(1)
Selling & marketing——(1)(2)(5)(9)(7)(5)(6)(7)
General & administrative(3)(3)(7)(6)(14)(12)(13)(9)(11)(19)
Total operating expenses(4)(4)(8)(9)(28)(22)(21)(15)(19)(29)
Operating income(3)(4)(7)(8)(25)(14)(9)(1)55
Interest expense(1)(1)(4)(2)(2)(7)(13)—(13)—
Other income (expense), net(3)(2)(4)(2)(6)(13)(1)(25)(37)7
Pre-tax income————————(33)12
Income tax expense0000000000
Net income(6)(6)(12)(10)(31)(27)(10)(26)(31)12
EPS — basic———($0.05)($0.08)($0.05)($0.02)($12.19)($7.03)$1.38
EPS — diluted———($0.05)($0.08)($0.05)($0.02)($12.19)($7.03)$0.41
Shares outstanding — basic (M)———204378518549249
Shares outstanding — diluted (M)———204378518549249

Showing the latest 10 of 16 fiscal years.

  • ⚑ Weighted-average shares changed ×9.71 between FY2012 and FY2019 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×1.85 between FY2019 and FY2020 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ÷Infinity between FY2022 and FY2023 — likely a reverse split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×2.00 between FY2023 and FY2024 — likely a stock split. Per-share figures on either side are as reported and not adjusted.
  • ⚑ Weighted-average shares changed ×2.25 between FY2024 and FY2025 — a large issuance or reduction. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.